II. Epidemiology
-
Hypothyroidism
Incidence in pregnancy (U.S.)
- Overt Hypothyroidism: 0.3 to 0.5% of pregnancies
- Subclinical Hypothyroidism: 2-3% of pregnancies
III. Precautions
- Maintaining euthyroid state in pregnancy is critical (see complications below)
- Endocrinology consult is recommended
- Avoid desiccated Thyroid (e.g. armour Thyroid) or Liothyronine (T3) in pregnancy
- Inadequate T4 for the fetus
IV. Findings
- See Hypothyroidism
V. Indications: Screening
VI. Labs: Serum TSH Monitoring protocol
- Initial testing
- Serum TSH at earliest pregnancy diagnosis (Levothyroxine increased at this time)
- Serum TSH 4-6 weeks after initial Levothyroxine increase (and then per protocol below)
- Subsequent testing in pregnancy
- Perinatal and postpartum TSH
VII. Management: Clinical Hypothyroidism onset in Pregnancy
- Clinical Hypothyroidism (esp. Hashimoto Thyroiditis) complicates 2 per 1000 pregnancies
- Start Levothyroxine and titrate based on every 4-6 week TSH monitoring
VIII. Management: Levothyroxine increased dose at onset of pregnancy
- Pregnancy requires an increased Levothyroxine dose
- See Thyroid Dysfunction in Pregnancy
- Increased dose by 30-47% over baseline required in most pregnant patients
- Increased dose required for remainder of pregnancy (with frequent monitoring of TSH)
- Increase Levothyroxine dose at earliest knowledge of pregnancy
- Achieve euthyroid state as soon as possible
- Recheck Serum TSH 4-6 weeks (30-40 days) after Levothyroxine dose start and dose change
- Educate patient to take Levothyroxine at consistent time and preferably 4 hours apart from PNV
- Add 2 additional doses per week (9 total doses)
- After a first missed menstrual period or positive Pregnancy Test
- Patient adds 2 additional Levothyroxine doses per week AND
- Notify treating medical provider
- Example
- Patient on 100 mcg daily before pregnancy
- When pregnancy diagnosed, start taking an extra dose (total 200 mcg) on Tuesday and Saturday
- Recheck Thyroid Stimulating Hormone (TSH) at 4-6 weeks after dose change
- Efficacy
- Dose adjustment safely and completely prevents TSH increase above 5.0 mIU/L
- Prevents >2.5 mIU/L in 85% of cases
- Yassa (2010) J Clin Endocrinol Metab 95(7): 3234-41 [PubMed]
- After a first missed menstrual period or positive Pregnancy Test
IX. Management: Levothyroxine dose adjustment during pregnancy
- Initiate Levothyroxine dosing protocol following the initial increase in Levothyroxine dose at pregnancy diagnosis
- Goal Thyroid Stimulating Hormone
- Goal TSH <2.5 mcg/day preconception and first trimester
- Goal TSH <3.0 for second and third trimester
- Abalovich (2007) J Clin Endocrinol Metab 92(8 Suppl):S1-47 [PubMed]
-
Thyroid Stimulating Hormone (TSH): 2.5-5.0 mIU/L (or 3.0 to 5.0 after first trimester)
- Increase daily Levothyroxine dose by 12.5-25 mcg/day
-
Thyroid Stimulating Hormone (TSH): 5-10 mIU/L
- Increase daily Levothyroxine dose by 25-50 mcg/day
-
Thyroid Stimulating Hormone (TSH): 10-20 mIU/L
- Increase daily Levothyroxine dose by 50-75 mcg/day
-
Thyroid Stimulating Hormone (TSH): >20 mIU/L
- Increase daily Levothyroxine dose by 75-100 mcg/day
X. Management: Postpartum Levothyroxine dosing
- Gradually decrease dose to baseline (pre-pregnant dose) over first 4 weeks after delivery
- Recheck Serum TSH at 4-6 weeks after delivery
XI. Complications
- Decreased with Thyroid Replacement (Levothyroxine)
- Miscarriage
- Preterm Birth
- Fetal cognitive deficits
- Not affected by Thyroid Replacement
- Hypertensive Disorders of Pregnancy (including Preeclampsia)
- Low birth weight or Preterm birth
- Placental Abruption